Media Newsroom of

Regis Technologies

Follow on Social Network
8210 Austin Avenue
Morton Grove, IL 60053

Regis Technologies is a CDMO focused on small molecule, active pharmaceutical ingredients. They provide synthesis, analytical, and manufacturing services to pharmaceutical and biotechnology companies from development through commercialization.

Regis Technologies' 2019 FDA Inspection Yields NAI Classification (Zero 483s)

Regis Technologies' 2019 FDA Inspection Yields NAI Classification (Zero 483s)

​​​​Regis Technologies, Inc. reports the successful outcome of its routine U.S. Food & Drug Administration (FDA) inspection, which found no objectionable findings, meaning no Form 483 observations were issued. This marks the fourth consecutive, impeccable inspection for Regis and demonstrates…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login